Literature DB >> 3083119

Percutaneous management of upper tract transitional cell carcinoma.

S B Streem, E J Pontes.   

Abstract

Conservative (nephron-sparing) surgery for transitional cell carcinoma of the upper tract generally has entailed variations of partial nephrectomy or open pyelotomy with excision and fulguration of tumor. We report on a patient in whom percutaneous technology was used successfully to manage transitional cell carcinoma of the lower infundibulum after other treatment options had been exhausted.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083119     DOI: 10.1016/s0022-5347(17)45847-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Ureteroscopic management of upper urinary tract urothelial malignancies.

Authors:  M Grasso
Journal:  Rev Urol       Date:  2000

Review 2.  Intracavitary immunotherapy and chemotherapy for upper urinary tract cancer: current evidence.

Authors:  Luca Carmignani; Roberto Bianchi; Gabriele Cozzi; Angelica Grasso; Nicola Macchione; Carlo Marenghi; Sara Melegari; Marco Rosso; Elena Tondelli; Augusto Maggioni
Journal:  Rev Urol       Date:  2013

3.  Safety and efficacy of supracostal superior calyceal approach for percutaneous renal surgery.

Authors:  Mufti Mahmood Ahmed; Fayaz Ahmad Najar
Journal:  Turk J Urol       Date:  2018-12-04

4.  Treatment of upper tract urothelial carcinoma: a review of surgical and adjuvant therapy.

Authors:  Kalyan C Latchamsetty; Christopher R Porter
Journal:  Rev Urol       Date:  2006

5.  Percutaneous resection of upper tract urothelial cell carcinoma: When, how, and is it safe?

Authors:  Willem E Strijbos; Bart van der Heij
Journal:  Asian J Urol       Date:  2016-05-27

6.  Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma.

Authors:  Piyush Bhargav Sarmah; Syed Ali Ehsanullah; Bhupendra Dev Sarmah
Journal:  Indian J Urol       Date:  2020-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.